NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 158
Auteur Titel [ Jaar(Asc)]
Filters: Auteur is Cor A DeJong  [Alle filters opschonen]
2014
VanDerNagel JEl, Kiewik M, Postel MG, van Dijk M, Didden R, Buitelaar JK, DeJong CA.  2014.  Capture recapture estimation of the prevalence of mild intellectual disability and substance use disorder.. Res Dev Disabil. 35(4):808-13.
van Noorden MS, Kamal RM, Dijkstra BAG, Mauritz R, DeJong CA.  2014.  A Case Series of Pharmaceutical Gamma-Hydroxybutyrate in 3 Patients With Severe Benzodiazepine-Resistant Gamma-Hydroxybutyrate Withdrawal in the Hospital.. Psychosomatics.
DeJong CA, de Kanter W.  2014.  [Commerce and psychoactive substances: beware Greeks bearing gifts].. Ned Tijdschr Geneeskd. 158:A8380.
Schellekens A, DeJong CA, Buitelaar JK, Verkes RJ.  2014.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment.. Eur Psychiatry.
Kamal RM, van Iwaarden S, Dijkstra BAG, DeJong CA.  2014.  Decision rules for GHB (gamma-hydroxybutyric acid) detoxification: a vignette study.. Drug Alcohol Depend. 135:146-51.
Iskandar S, Trianda P, Fitriana E, Pinxten L, DeJong CA.  2014.  Experience in care, burden, and hope of the family members of HIV patients with and without a history of injecting drug use in Indonesia: An exploratory case. Mental Health and Substance Use.
Dijkstra BAG, Schellekens A, DeJong CA.  2014.  GHB-detoxificatie in Nederland. Tijdschrift voor Verslaving. 3
Meijerink H, Indrati A, Soedarmo S, Utami F, DeJong CA, Alisjahbana B, van Crevel R, Wisaksana R, Van der Ven AJAM.  2014.  Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower ex-vivo production of CCR5 ligands.. AIDS.
Markus W, de Kruijk C, van Oene GH de Weert, Becker ES, DeJong CA.  2014.  One size fits few. Een pleidooi voor geïntegreerd behandelen van PTSS en verslaving.. Dth. 34(3)
Kok T, de Haan HA, van der Meer M, Najavits LM, DeJong CA.  2014.  Screening of current PTSD in substance use disorder patients with the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure. European Addiction Research.
2013
Schellekens A, DeJong CA, Buitelaar JK, Verkes RJ.  2013.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. European Psychiatry. 30(1):128–136.
van Oene GH de Weert, Schellekens A, Dijkstra BAG, Kamal RM, DeJong CA.  2013.  Detoxification of patients with GHB dependence.. Tijdschr Psychiatr. 55(11):885-90.
Pinxten L, DeJong CA, Hidayat T, Istiqomah AN, Achmad YM, Raya RP, Norviatin D, Siregar I.M.P..  2013.  Developing a Competence-Based Addiction Medicine Curriculum in Indonesia: The Training Needs Assessment. International Perspectives on Training in Addiction Medicine. Ed: Paul Haber.
Ter Huurne ED, Postel MG, de Haan HA, DeJong CA.  2013.  Effectiveness of a web-based treatment program using intensive therapeutic support for female patients with bulimia nervosa, binge eating disorder and eating disorders not otherwise specified: study protocol of a randomized controlled trial.. BMC Psychiatry. 13(1):310.
Kok T, de Haan HA, van der Meer M, Najavits LM, DeJong CA.  2013.  Efficacy of "seeking safety" in a Dutch population of traumatized substance-use disorder outpatients: study protocol of a randomized controlled trial.. BMC Psychiatry. 13:162.
Istriana E, Kurnia A, Weijers A, Hidayat T, Pinxten L, DeJong CA, Schellekens A.  2013.  Excellent reliability of the Hamilton Depression Rating Scale (HDRS-21) in Indonesia after training.. Asia Pac Psychiatry.
de Haan HA, Joosten EAG, de Haan L, Schellekens A, Buitelaar JK, van der Palen J, DeJong CA.  2013.  A family history of alcoholism relates to alexithymia in substance use disorder patients.. Compr Psychiatry.
Dijkstra BAG, van Oene GH de Weert, Verbrugge C, DeJong CA.  2013.  GHB Detoxificatie met farmaceutische GHB. Eindrapportage van de monitoring van DeTiTap® in de Nederlandse verslavingszorg.
Qurishi R, Sonneborn C, de Jong-Arts M, DeJong CA.  2013.  Premenstrual syndrome and self-medication with opioids.. J Addict Med. 7(1):79-82.
van Oene GH de Weert, DeJong CA, Raes V, de Haan HA.  2013.  Probleemidentificatie, diagnostiek en monitoring bij dubbele diagnose. Handboek Dubbele Diagnose. :41-54.
Dijkstra BAG, van Oene GH de Weert, Kamal RM, DeJong CA.  2013.  Richtlijn om met GHB te stoppen. Afkickrichtlijn is steun in de rug voor zorgverleners en onderzoekers. Medisch Contact. 27
Bruijnen CJWH, Wester AJ, Markus W, DeJong CA, Kessels RP.  2013.  Screening of cognitive disorders in substance abuse patients using the Montreal Cognitive Assessment - Dutch Version (MoCA-D). Journal of the International Neuropsychological Society. 19(Suppl 2)
Iskandar S, van Crevel RR, Hidayat T, Siregar IMP, Achmad TH, van der Ven AJAM, DeJong CA.  2013.  Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia.. Am J Addict. 22(5):425-31.
DeJong CA, Luycks L, Delicat JW.  2013.  [Training in addiction medicine].. Ned Tijdschr Geneeskd. 157(22):A5751.
DeJong CA, Kamal RM, Van Noorden M, Broers B.  2013.  Treatment of GHB Withdrawal Syndrome: Catch 22 or Challenge for Addiction Medicine? Addiction.

Pagina's